Skip to main content
. Author manuscript; available in PMC: 2016 Mar 23.
Published in final edited form as: Leuk Res. 2011 Feb 12;35(6):814–820. doi: 10.1016/j.leukres.2010.12.028

Figure 4. Synergistic growth arrest and apoptosis with antimycin A and 3-BrOP.

Figure 4

Average +/− SD of three samples shown in each graph. A, Viability of pre-B (Nalm6 and JM1) and T-ALL (SupT1 and Molt4) lines treated with antimycin A for 48 hours measured by AlamarBlue assay. B, Viable cell count in pre-B (Nalm6) and T-ALL (Molt4) cells treated with Antimycin A for 48 hours. C, Sub-G0 content measured by flow cytometry following TPI staining in pre-B ALL (Nalm6) cells treated with antimycin A and 3-BrOP for 48 hours. D, Viability in pre-B ALL (Nalm6) following combined treatment with 1mcM Antimycin A and/or 15mcM 3-BrOP for 48 hours, measured by AlamarBlue assay.